1 Non-GAAP cost of product revenues excludes the amortization of licensed intellectual property for Iclusig relating to the acquisition of the European business of ARIAD Pharmaceuticals, Inc. and the ...

Our earnings release contains some or all of the following financial measures that have not been calculated in accordance with United States Generally Accepted Accounting Principles (“GAAP”): (i) ...

(1) Item represents a non-GAAP financial measure; see discussion below, as well as a reconciliation to the comparable GAAP measure in the financial tables in this earnings press release. “During our ...

(1) Estimated adjustments to GAAP earnings per share are shown after income tax effects. (2) Reflects charges related to a restructuring plan announced on August 14, 2024. We expect this plan to be ...

In nCino’s public disclosures, nCino has provided non-GAAP measures, which are measurements of financial performance that have not been prepared in accordance with generally accepted accounting ...

Fourth quarter service revenue of $172 million and total revenue of $177 million Fiscal year 2025 service revenue of $693 million and total revenue of $715 million 2025 Cash flow from operations of ...

(1) Estimated adjustments to GAAP earnings per share are shown after income tax effects. Margin and EPS guidance includes the estimated impact of tariffs based on current trade policy. Except as noted ...